Rebirthel Co., Ltd.

Booth 1353
Kyoto, Japan
Rebirthel Co., Ltd. will provide “allogeneic T cell therapy” using “off-the-shelf T cell preparations” to pioneer a new era of treating cancer and viral infectious diseases. We have multiple patented technologies that are essential for the realization of allogeneic immune cell therapy. We look forward to discussing potential collaborations for providing next-generation treatment by using our and/or your technologies.
Focus Areas